text-only page produced automatically by LIFT Text Transcoder Skip all navigation and go to page contentSkip top navigation and go to directorate navigationSkip top navigation and go to page navigation
National Science Foundation Home National Science Foundation - Mathematical & Physical Sciences (MPS)
Mathematical & Physical Sciences (MPS)
design element
MPS Home
About MPS
Funding Opportunities
Awards
News
Events
Discoveries
Publications
Advisory Committee
Career Opportunities
2013-2014 Distinguished Lecture Series
View MPS Staff
MPS Organizations
Astronomical Sciences (AST)
Chemistry (CHE)
Materials Research (DMR)
Mathematical Sciences (DMS)
Physics (PHY)
Office of Multidisciplinary Activities (OMA)
Proposals and Awards
Proposal and Award Policies and Procedures Guide
  Introduction
Proposal Preparation and Submission
bullet Grant Proposal Guide
  bullet Grants.gov Application Guide
Award and Administration
bullet Award and Administration Guide
Award Conditions
Other Types of Proposals
Merit Review
NSF Outreach
Policy Office
Other Site Features
Special Reports
Research Overviews
Multimedia Gallery
Classroom Resources
NSF-Wide Investments

Email this pagePrint this page
All Images

Discovery
Math Could Aid in Curing Cancer

Back to article | Note about images

Photo of a researcher in a lab.

Computers are common in hospitals, but can math cure cancer? In a recent study, researchers combined math and medicine to show that patients may be cured of leukemia with an optimally timed (mathematically derived) cancer vaccine.

Credit: © 2008 Jupiter Images Corporation

 

Lisa-Joy Zgorski of the National Science Foundation interviews mathematician Doron Levy of the University of Maryland on the application of mathematics in treating leukemia. Levy, along with Peter P. Lee, Stanford Medical School physician and associate professor of medicine (hematology) and Peter S. Kim, École Supérieure d'Électricité (Gif-sur-Yvette, France), describe their success in creating a mathematical model which predicts anti-leukemia immune response in CML patients using the drug imatinib in a way that might provide a cure for the disease. Their findings are detailsed in the June 20 edition of the journal PLoS Computational Biology.

Credit: University of Maryland, College Park/National Science Foundation

 



Email this pagePrint this page
Back to Top of page